Chemed (FRA:CXM) Equivalent Admissions # : 0.00 (As of . 20)

View and export this data going back to 2007. Start your Free Trial

What is Chemed Equivalent Admissions #?

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Chemed's Equivalent Admissions # or its related term are showing as below:

FRA:CXM's Equivalent Admissions # is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Chemed Equivalent Admissions # Historical Data

The historical data trend for Chemed's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed Equivalent Admissions # Chart

Chemed (FRA:CXM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (FRA:CXM) » Definitions » Equivalent Admissions #

Comparable Companies

Traded in Other Exchanges

CHE:USA

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.